30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Final Patient Treated in Active Implants' NUsurface Trials -

Active Implants announced treatment of the final patient in SUN and VENUS trials evaluating the NUsurface® Meniscus Implant for the treatment of persistent knee pain from injured or deteriorated meniscus tissue. The trials enrolled a combined 243 patients, 176 of which received NUsurface. The company is pursuing an FDA De Novo 510(k) clearance for the device. If cleared by FDA, NUsurface would be the first “artificial meniscus.” The implant has been used in Europe under CE Mark since 2008 and in Israel since 2011. (Active Implants LLC, 7/10/18)